{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:23:06Z","timestamp":1782264186004,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jiac.2024.12.017","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:24:06Z","timestamp":1734024246000},"page":"102588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risks and prevention of severe respiratory syncytial virus infection among infants and children with pulmonary hypoplasia, airway stenosis, congenital esophageal atresia, inborn errors of metabolism, or neuromuscular diseases in Japan"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-4866","authenticated-orcid":false,"given":"Masaaki","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7508-1330","authenticated-orcid":false,"given":"Naruhiko","family":"Ishiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-9696","authenticated-orcid":false,"given":"Kenta","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-7186","authenticated-orcid":false,"given":"Masayoshi","family":"Shinjoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7742-1135","authenticated-orcid":false,"given":"Munehiro","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-9089","authenticated-orcid":false,"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Hinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Korematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaya","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Ishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jiac.2024.12.017_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial viral infection in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N Engl J Med"},{"issue":"2Suppl","key":"10.1016\/j.jiac.2024.12.017_bib2","article-title":"Selected populations at increased risk from respiratory syncytial virus infection","volume":"22","author":"Meissner","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jiac.2024.12.017_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/cid\/cir928","article-title":"Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization:a population\uff0dbased cohort study","volume":"54","author":"Kristensen","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.12.017_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10156-010-0121-1","article-title":"Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan","volume":"17","author":"Mori","year":"2011","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.jiac.2024.12.017_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12887-021-02567-6","article-title":"Study protocol: a multicenter, uncontrolled, open-label study of palivizumab in neonates, infants, and preschool children at high risk of severe respiratory syncytial virus infection","volume":"21","author":"Mori","year":"2021","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jiac.2024.12.017_bib6","article-title":"Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial","volume":"39","author":"Mori","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jiac.2024.12.017_bib7","unstructured":"AstraZeneca K.K. Package insert- SYNAGIS\u00ae Solution 50mg, 100mg for intramuscular Administration (in Japanese) https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuSearch."},{"key":"10.1016\/j.jiac.2024.12.017_bib8","unstructured":"Japanese Society for Pediatric Infectious Diseases, Guideline Development Subcommittee.Guidance for the use of palivizumab in Japan for pulmonary hypoplasia, airway stenosis, congenital esophageal atresia, inborn errors of metabolism, and neuromuscular diseases. https:\/\/www.jspid.jp\/news\/guideline\/palivizumab_guidance\/(in Japanese)."},{"key":"10.1016\/j.jiac.2024.12.017_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ppul.22826","article-title":"Use of palivizumab in infants and young children with severe respiratory disease: a Delphi study","volume":"49","author":"Gaboli","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jiac.2024.12.017_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1442-200X.2008.02580.x","article-title":"Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia","volume":"50","author":"Masumoto","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2024.12.017_bib11","first-page":"235","article-title":"Risk of respiratory syncytial virus infection after congenital diaphragmatic hernia surgery","volume":"42","author":"Masumoto","year":"2006","journal-title":"J Jpn Soc Perin Neon Med"},{"key":"10.1016\/j.jiac.2024.12.017_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ped.12544","article-title":"Risk of respiratory syncytial virus infection in infants with congenital cystic lung disease","volume":"57","author":"Hama","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2024.12.017_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15007","article-title":"Development of individuals with thanatophoric dysplasia surviving beyond infancy","volume":"64","author":"Ushioda","year":"2022","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jiac.2024.12.017_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00431-015-2641-2","article-title":"Lethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birth","volume":"175","author":"Okazaki","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jiac.2024.12.017_bib15","unstructured":"Sweden, Medical Products Agency: http:\/\/www.lakemedelsverket.se\/malgrupp\/Halso---sjukvard\/Behandlings--rekommendationer\/Behandlingsrekommendation---listan\/RSV-infektioner\/."},{"key":"10.1016\/j.jiac.2024.12.017_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jiac.2024.12.017_bib17","first-page":"1167","article-title":"Current state of neonatal surgery in Japan - national statistics on neonatal surgery in 2018-","volume":"56","author":"Usui","year":"2020","journal-title":"J Jpn Soc Pediatr Surg"},{"key":"10.1016\/j.jiac.2024.12.017_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.braindev.2019.01.008","article-title":"Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: divergent clinical outcomes in two Japanese siblings","volume":"41","author":"Yamazaki","year":"2019","journal-title":"Brain Dev"},{"key":"10.1016\/j.jiac.2024.12.017_bib19","first-page":"27","article-title":"A case of mitochondrial disease in which myocardial disorder became apparent after RSV infection","volume":"38","author":"Shinozaki","year":"2018","journal-title":"Journal of Sendai City Hospital"},{"key":"10.1016\/j.jiac.2024.12.017_bib20","first-page":"39","article-title":"A case of an infant with carnitine palmitoyltransferase 2 (CPT2) deficiency discovered through neonatal mass screening who developed rhabdomyolysis during respiratory syncytial virus infection","volume":"52","author":"Ishige","year":"2016","journal-title":"Bulletin on Special Formula"},{"key":"10.1016\/j.jiac.2024.12.017_bib21","first-page":"162","article-title":"Investigation of acute illness in infants detected through newborn mass screening using the tandem mass method","volume":"32","author":"Ishige","year":"2016","journal-title":"Japanese J Inher Metabolic Dise"},{"key":"10.1016\/j.jiac.2024.12.017_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/INF.0000000000001340","article-title":"Outcomes of infants receiving palivizumab prophylaxis for respiratory syncytial virus in Canada and Italy: an international, prospective cohort study","volume":"36","author":"Manzoni","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2024.12.017_bib23","first-page":"927","article-title":"Nationwide survey of severe respiratory syncytial virus infection in children ; relationship with underlying diseases and medical care","volume":"124","author":"Watabe","year":"2020","journal-title":"J Jpn Pediatr Soc"},{"key":"10.1016\/j.jiac.2024.12.017_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/INF.0b013e31805d01e3","article-title":"Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course","volume":"26","author":"Wilkesmann","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2024.12.017_bib25","unstructured":"Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants, Published: June 1, 2022, Public Health Agency of Canada. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/palivizumab-respiratory-syncitial-virus-infection-infants.html."},{"key":"10.1016\/j.jiac.2024.12.017_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/ped.14410","article-title":"The working group for revision of \u201cguidelines for the use of palivizumab in Japan\u201d: a committee report","volume":"62","author":"Okada","year":"2020","journal-title":"Pediatr Int"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:19:25Z","timestamp":1750137565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1341321X24003350"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.12.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks and prevention of severe respiratory syncytial virus infection among infants and children with pulmonary hypoplasia, airway stenosis, congenital esophageal atresia, inborn errors of metabolism, or neuromuscular diseases in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102588"}}